112 related articles for article (PubMed ID: 24761459)
1. EQ-5D-Y as a health-related quality of life measure in children and adolescents with functional disability in Sweden: testing feasibility and validity.
Burström K; Bartonek Å; Broström EW; Sun S; Egmar AC
Acta Paediatr; 2014 Apr; 103(4):426-35. PubMed ID: 24761459
[TBL] [Abstract][Full Text] [Related]
2. Measuring health-related quality of life with the EQ-5D-Y instrument in children and adolescents with asthma.
Bergfors S; Åström M; Burström K; Egmar AC
Acta Paediatr; 2015 Feb; 104(2):167-73. PubMed ID: 25393977
[TBL] [Abstract][Full Text] [Related]
3. EQ-5D-Y-5L as a patient-reported outcome measure in psychiatric inpatient care for children and adolescents - a cross-sectional study.
Åström M; Krig S; Ryding S; Cleland N; Rolfson O; Burström K
Health Qual Life Outcomes; 2020 Jun; 18(1):164. PubMed ID: 32493419
[TBL] [Abstract][Full Text] [Related]
4. A comparison of the EQ-5D-3L and ICECAP-O in an older post-acute patient population relative to the general population.
Couzner L; Crotty M; Norman R; Ratcliffe J
Appl Health Econ Health Policy; 2013 Aug; 11(4):415-25. PubMed ID: 23807538
[TBL] [Abstract][Full Text] [Related]
5. Assessing the Health-Related Quality of Life of Australian Adolescents: An Empirical Comparison of the Child Health Utility 9D and EQ-5D-Y Instruments.
Chen G; Flynn T; Stevens K; Brazier J; Huynh E; Sawyer M; Roberts R; Ratcliffe J
Value Health; 2015 Jun; 18(4):432-8. PubMed ID: 26091597
[TBL] [Abstract][Full Text] [Related]
6. Testing a Swedish child-friendly pilot version of the EQ-5D instrument--initial results.
Burström K; Svartengren M; Egmar AC
Eur J Public Health; 2011 Apr; 21(2):178-83. PubMed ID: 20430806
[TBL] [Abstract][Full Text] [Related]
7. Population health status based on the EQ-5D-Y-3L among adolescents in Sweden: Results by sociodemographic factors and self-reported comorbidity.
Åström M; Persson C; Lindén-Boström M; Rolfson O; Burström K
Qual Life Res; 2018 Nov; 27(11):2859-2871. PubMed ID: 30196340
[TBL] [Abstract][Full Text] [Related]
8. A comparison of the performance of the EQ-5D and the EQ-5D-Y health-related quality of life instruments in South African children.
Jelsma J
Int J Rehabil Res; 2010 Jun; 33(2):172-7. PubMed ID: 20351650
[TBL] [Abstract][Full Text] [Related]
9. Cross-sectional validity of the EQ-5D-Y as a generic health outcome instrument in children and adolescents with cystic fibrosis in Germany.
Eidt-Koch D; Mittendorf T; Greiner W
BMC Pediatr; 2009 Aug; 9():55. PubMed ID: 19715563
[TBL] [Abstract][Full Text] [Related]
10. The use of the EQ-5D-Y health related quality of life outcome measure in children in the Western Cape, South Africa: psychometric properties, feasibility and usefulness - a longitudinal, analytical study.
Scott D; Ferguson GD; Jelsma J
Health Qual Life Outcomes; 2017 Jan; 15(1):12. PubMed ID: 28103872
[TBL] [Abstract][Full Text] [Related]
11. Acceptability of the health-related quality of life instrument EQ-5D-Y-5L among patients in child and adolescent psychiatric inpatient care.
Krig S; Åström M; Kulane A; Burström K
Acta Paediatr; 2021 Mar; 110(3):899-906. PubMed ID: 32815186
[TBL] [Abstract][Full Text] [Related]
12. Prevalence and prognostic factors of disability after childhood injury.
Polinder S; Meerding WJ; Toet H; Mulder S; Essink-Bot ML; van Beeck EF
Pediatrics; 2005 Dec; 116(6):e810-7. PubMed ID: 16322139
[TBL] [Abstract][Full Text] [Related]
13. [EuroQol-5D FOR quality of life assessment in cardiac rehabilitation].
Balestroni G; Omarini G; Omarini P; Zotti AM
G Ital Med Lav Ergon; 2007; 29(3 Suppl B):B56-62. PubMed ID: 18575359
[TBL] [Abstract][Full Text] [Related]
14. [Validity and reliability of the spanish EQ-5D-Y proxy version].
Gusi N; Perez-Sousa MA; Gozalo-Delgado M; Olivares PR
An Pediatr (Barc); 2014 Oct; 81(4):212-9. PubMed ID: 24411558
[TBL] [Abstract][Full Text] [Related]
15. Predictors of self-reported health-related quality of life according to the EQ-5D-Y in chronically ill children and adolescents with asthma, diabetes, and juvenile arthritis: longitudinal results.
Otto C; Barthel D; Klasen F; Nolte S; Rose M; Meyrose AK; Klein M; Thyen U; Ravens-Sieberer U
Qual Life Res; 2018 Apr; 27(4):879-890. PubMed ID: 29189988
[TBL] [Abstract][Full Text] [Related]
16. Feasibility, reliability, and validity of the EQ-5D-Y: results from a multinational study.
Ravens-Sieberer U; Wille N; Badia X; Bonsel G; Burström K; Cavrini G; Devlin N; Egmar AC; Gusi N; Herdman M; Jelsma J; Kind P; Olivares PR; Scalone L; Greiner W
Qual Life Res; 2010 Aug; 19(6):887-97. PubMed ID: 20401552
[TBL] [Abstract][Full Text] [Related]
17. Validation of the EQ-5D in patients with a history of acute coronary syndrome.
Ellis JJ; Eagle KA; Kline-Rogers EM; Erickson SR
Curr Med Res Opin; 2005 Aug; 21(8):1209-16. PubMed ID: 16083530
[TBL] [Abstract][Full Text] [Related]
18. Clinical validity of a disease-specific health status questionnaire: the peripheral artery questionnaire.
Hoeks SE; Smolderen KG; Scholte Op Reimer WJ; Verhagen HJ; Spertus JA; Poldermans D
J Vasc Surg; 2009 Feb; 49(2):371-7. PubMed ID: 19028064
[TBL] [Abstract][Full Text] [Related]
19. An investigation into the empirical validity of the EQ-5D and SF-6D based on hypothetical preferences in a general population.
Petrou S; Hockley C
Health Econ; 2005 Nov; 14(11):1169-89. PubMed ID: 15942981
[TBL] [Abstract][Full Text] [Related]
20. Does the EQ-5D measure quality of life in schizophrenia?
Halling Hastrup L; Nordentoft M; Hjorthøj C; Gyrd-Hansen D
J Ment Health Policy Econ; 2011 Dec; 14(4):187-96. PubMed ID: 22345360
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
